다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Black Diamond Therapeutics Inc (BDTX)
Black Diamond Therapeutics Inc (BDTX) 뉴스

BDTX

Black Diamond Therapeutics (BDTX)

Black Diamond Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BDTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/01	23:00	GlobeNewswire Inc.	Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/05/29	21:00	GlobeNewswire Inc.	Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/05/14	08:09	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/05/09	20:30	GlobeNewswire Inc.	Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/05/09	20:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/05/09	20:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/04/25	05:05	GlobeNewswire Inc.	Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/04/11	21:00	GlobeNewswire Inc.	Black Diamond Therapeutics Announces Changes to Board of Directors	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/04/08	07:00	GlobeNewswire Inc.	Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/04/03	21:00	GlobeNewswire Inc.	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/03/12	21:00	GlobeNewswire Inc.	Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/03/12	02:14	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/03/06	06:30	GlobeNewswire Inc.	Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/02/28	22:00	GlobeNewswire Inc.	Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/02/16	07:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/02/16	07:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/02/16	07:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/02/16	07:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/02/15	00:04	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/01/19	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/01/04	22:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2024/01/04	22:00	GlobeNewswire Inc.	Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2023/12/13	21:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2023/12/13	21:00	GlobeNewswire Inc.	Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2023/11/07	22:00	GlobeNewswire Inc.	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2023/11/06	21:45	GlobeNewswire Inc.	Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2023/11/06	21:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2023/11/06	21:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2023/10/15	01:30	GlobeNewswire Inc.	Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535	NASDAQ:BDTX	Black Diamond Therapeutics Inc
2023/10/05	01:14	GlobeNewswire Inc.	Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	NASDAQ:BDTX	Black Diamond Therapeutics Inc

검색 관련기사 보기:NASDAQ:BDTX

1 2 3 4 5 6 7 8 9 10 다음 >>

JP Morgan ETFs Ireland I... (GM)

NLBNPIT1V207 20991231 15...

First Trust Horizon Mana...

Credit Agricole Financem...

Bofa Finance Llc Autocal...

Scottie Resources

Bioasis Technologies (CE)

NLBNPIT1W9A6 20351221 30...

Bellevue Gold (PK)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관